MedTrace Logo

Tracking CF Lung Disease Through the Early Years: Utility of the LCI

NCT03138772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2021-09-21

No results posted yet for this study

Summary

This is a prospective observational study to follow a cohort of patients with Cystic Fibrosis and healthy controls for a period of two years. This study will include monitoring the subjects lung clearance index (by performing a breathing test called the multiple breath washout), as well as spirometry and their respiratory symptoms every three months as well as during a pulmonary exacerbation and after their recovery.

Conditions

  • Observational

Interventions

OTHER

This is an observational study, no intervention used.

No intervention is being used in this study.

Sponsors & Collaborators

  • Felix Ratjen

    lead OTHER

Principal Investigators

  • Felix Ratjen, MD · The Hospital for Sick Children

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-05
Primary Completion
2020-10-01
Completion
2021-09-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03138772 on ClinicalTrials.gov